Elżbieta Bylina

Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience

Piotr Rutkowski, Alessandro Gronchi, Peter Hohenberger et al. · Annals of Surgical Oncology · 2013 · 242 citations

Medicine, Oncology, Gastrointestinal Oncology +11

Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST

Agnieszka Woźniak, Piotr Rutkowski, Patrick Schöffski et al. · Clinical Cancer Research · 2014 · 179 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes

Piotr Rutkowski, Elżbieta Bylina, Agnieszka Woźniak et al. · European Journal of Surgical Oncology · 2011 · 170 citations

Medicine, Oncology, Surgery +12

Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience

Agnieszka Woźniak, Piotr Rutkowski, A Piskorz et al. · Annals of Oncology · 2011 · 161 citations · Full text

Medicine, Oncology, Pathology +14

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

Piotr Rutkowski, Elżbieta Bylina, Anna Klimczak et al. · BMC Cancer · 2012 · 95 citations · Full text

Medicine, Oncology, Pharmacotherapy +17